[1]
K. Hoshtynar, M. Khaitovych, O. Kryvanych, and V. Potaskalova, “Drug-related problems in comorbid patients with anxiety-depressive disorders”, ScienceRise: Pharmaceutical Science, no. 4 (56), pp. 56–64, Aug. 2025.